Posaconazole delayed-release tablets in paediatric haematology-oncology patients.

Margherita MauroAntonella ColombiniKatia PerruccioDaniele ZamaMaria Rosaria D'AmicoElisabetta CaloreFrancesca CarraroPaola MuggeoGloria TridelloValentina BarettaSimone Cesaro

Published in: Mycoses (2020)

Posaconazole DRT is feasible in paediatric patients capable to swallow tablets. Specific pharmacokinetic studies are needed.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
intensive care unit
emergency department
peritoneal dialysis
patient reported outcomes
patient reported